NCT06391515View on ClinicalTrials.gov

Subacute Thyroiditis in the SARS-CoV-2 Era

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

November 23, 2020

Primary Completion Date

May 23, 2022

Study Completion Date

September 14, 2023

Conditions
Subacute ThyroiditisSARS CoV 2 InfectionThyrotoxicosis
Interventions
DIAGNOSTIC_TEST

Blood sample, CRF, thyroid ultrasound

Five visits were planned: at diagnosis (V0) and after 1, 3, 6 and 12 months (V1, V2, V3 and V4, respectively). At each visit, subjects were evaluated with anamnesis, physical examination, thyroid US and blood tests.

Trial Locations (1)

41125

University of Modena and Reggio Emilia, Modena

All Listed Sponsors
lead

University of Modena and Reggio Emilia

OTHER

NCT06391515 - Subacute Thyroiditis in the SARS-CoV-2 Era | Biotech Hunter | Biotech Hunter